Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-dose pharmacokinetics of temocillin in plasma and soft tissues of healthy volunteers after intravenous and subcutaneous administration: a randomized crossover microdialysis trial.
Matzneller P, Ngougni Pokem P, Capron A, Lackner E, Wulkersdorfer B, Nussbaumer-Pröll A, Österreicher Z, Duchek M, Van de Velde S, Wallemacq PE, Mouton JW, Van Bambeke F, Zeitlinger M. Matzneller P, et al. Among authors: van de velde s, van bambeke f. J Antimicrob Chemother. 2020 Sep 1;75(9):2650-2656. doi: 10.1093/jac/dkaa176. J Antimicrob Chemother. 2020. PMID: 32433753 Clinical Trial.
Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
Seral C, Barcia-Macay M, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F. Seral C, et al. Among authors: van bambeke f. J Antimicrob Chemother. 2005 Apr;55(4):511-7. doi: 10.1093/jac/dki059. Epub 2005 Feb 24. J Antimicrob Chemother. 2005. PMID: 15731197
Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Barcia-Macay M, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F. Barcia-Macay M, et al. Among authors: van bambeke f. J Antimicrob Chemother. 2006 Dec;58(6):1177-84. doi: 10.1093/jac/dkl424. Epub 2006 Oct 24. J Antimicrob Chemother. 2006. PMID: 17062609
Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts).
Barcia-Macay M, Mouaden F, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F. Barcia-Macay M, et al. Among authors: van bambeke f. J Antimicrob Chemother. 2008 Jun;61(6):1288-94. doi: 10.1093/jac/dkn120. Epub 2008 Mar 27. J Antimicrob Chemother. 2008. PMID: 18375379 Free PMC article.
Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes.
Van de Velde S, Nguyen HA, Van Bambeke F, Tulkens PM, Grellet J, Dubois V, Quentin C, Saux MC. Van de Velde S, et al. Among authors: van bambeke f. J Antimicrob Chemother. 2008 Sep;62(3):518-21. doi: 10.1093/jac/dkn232. Epub 2008 Jun 10. J Antimicrob Chemother. 2008. PMID: 18544595
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains.
Nguyen HA, Denis O, Vergison A, Theunis A, Tulkens PM, Struelens MJ, Van Bambeke F. Nguyen HA, et al. Among authors: van bambeke f. Antimicrob Agents Chemother. 2009 Apr;53(4):1434-42. doi: 10.1128/AAC.01145-08. Epub 2009 Feb 2. Antimicrob Agents Chemother. 2009. PMID: 19188393 Free PMC article.
236 results